Literature DB >> 27480253

Nuclear alpha spectrin: Critical roles in DNA interstrand cross-link repair and genomic stability.

Muriel W Lambert1.   

Abstract

Non-erythroid alpha spectrin (αIISp) is a structural protein which we have shown is present in the nucleus of human cells. It interacts with a number of nuclear proteins such as actin, lamin, emerin, chromatin remodeling factors, and DNA repair proteins. αIISp's interaction with DNA repair proteins has been extensively studied. We have demonstrated that nuclear αIISp is critical in DNA interstrand cross-link (ICL) repair in S phase, in both genomic (non-telomeric) and telomeric DNA, and in maintenance of genomic stability following ICL damage to DNA. We have proposed that αIISp acts as a scaffold aiding to recruit repair proteins to sites of damage. This involvement of αIISp in ICL repair and telomere maintenance after ICL damage represents new and critical functions for αIISp. These studies have led to development of a model for the role of αIISp in DNA ICL repair. They have been aided by examination of cells from patients with Fanconi anemia (FA), a repair-deficient genetic disorder in which a deficiency in αIISp leads to defective ICL repair in genomic and telomeric DNA, telomere dysfunction, and chromosome instability following DNA ICL damage. We have shown that loss of αIISp in FA cells is due to increased breakdown by the protease, µ-calpain. Importantly, we have demonstrated that this deficiency can be corrected by knockdown of µ-calpain and restoring αIISp levels to normal. This corrects a number of the phenotypic deficiencies in FA after ICL damage. These studies suggest a new and unexplored direction for therapeutically restoring genomic stability in FA cells and for correcting numerous phenotypic deficiencies occurring after ICL damage. Developing a more in-depth understanding of the importance of the interaction of αIISp with other nuclear proteins could significantly enhance our knowledge of the consequences of loss of αIISp on critical nuclear processes.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  DNA interstrand cross-links; DNA repair; Fanconi anemia; Non-erythroid alpha spectrin; chromosome stability; telomere dysfunction; telomeres

Mesh:

Substances:

Year:  2016        PMID: 27480253      PMCID: PMC4999628          DOI: 10.1177/1535370216662714

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  103 in total

1.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.

Authors:  James M Holaska; Katherine L Wilson
Journal:  Biochemistry       Date:  2007-07-10       Impact factor: 3.162

2.  SH2 and SH3 domains. Unraveling signaling networks with peptide antagonists.

Authors:  R Stein
Journal:  Methods Mol Biol       Date:  1998

3.  Cell organization, growth, and neural and cardiac development require αII-spectrin.

Authors:  Michael C Stankewich; Carol D Cianci; Paul R Stabach; Lan Ji; Anjali Nath; Jon S Morrow
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

4.  A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNA.

Authors:  D W Brois; L W McMahon; N I Ramos; L M Anglin; C E Walsh; M W Lambert
Journal:  Carcinogenesis       Date:  1999-09       Impact factor: 4.944

5.  Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain.

Authors:  Gaël Nicolas; Catherine M Fournier; Colette Galand; Laurence Malbert-Colas; Odile Bournier; Yolande Kroviarski; Monique Bourgeois; Jacques H Camonis; Didier Dhermy; Bernard Grandchamp; Marie-Christine Lecomte
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 6.  Telomeres: protecting chromosomes against genome instability.

Authors:  Roderick J O'Sullivan; Jan Karlseder
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02-03       Impact factor: 94.444

Review 7.  Molecular pathogenesis of Fanconi anemia: recent progress.

Authors:  Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

8.  XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4.

Authors:  Daisy Klein Douwel; Rick A C M Boonen; David T Long; Anna A Szypowska; Markus Räschle; Johannes C Walter; Puck Knipscheer
Journal:  Mol Cell       Date:  2014-04-10       Impact factor: 17.970

Review 9.  Spectrin tethers and mesh in the biosynthetic pathway.

Authors:  M A De Matteis; J S Morrow
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

10.  The SH3 domain of alphaII spectrin is a target for the Fanconi anemia protein, FANCG.

Authors:  Joel A Lefferts; Chuan Wang; Deepa Sridharan; Melissa Baralt; Muriel W Lambert
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

View more
  6 in total

1.  The functional importance of lamins, actin, myosin, spectrin and the LINC complex in DNA repair.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-04

2.  Spectrin-based pathways underlying electrical and mechanical dysfunction in cardiac disease.

Authors:  Sathya D Unudurthi; Amara Greer-Short; Nehal Patel; Drew Nassal; Thomas J Hund
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-12-26

Review 3.  Regulation of Cardiac Conduction and Arrhythmias by Ankyrin/Spectrin-Based Macromolecular Complexes.

Authors:  Drew Nassal; Jane Yu; Dennison Min; Cemantha Lane; Rebecca Shaheen; Daniel Gratz; Thomas J Hund
Journal:  J Cardiovasc Dev Dis       Date:  2021-04-29

Review 4.  The Role of Nonerythroid Spectrin αII in Cancer.

Authors:  Anne Ackermann; Angela Brieger
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

Review 5.  DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.

Authors:  Sonali Bhattacharjee; Saikat Nandi
Journal:  Cell Commun Signal       Date:  2017-10-10       Impact factor: 5.712

Review 6.  Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy.

Authors:  Sonali Bhattacharjee; Saikat Nandi
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.